VRS
MLYS icon

Virginia Retirement Systems’s Mineralys Therapeutics MLYS Stock Holding History

Virginia Retirement Systems’s Portfolio MLYS Stock Details MLYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$333K Buy
12,350
+2,600
+27% +$71.3K ﹤0.01% 1092
2026
Q1 		$264K Buy
9,750
+400
+4% +$11.7K ﹤0.01% 866
2025
Q4 		$339K Buy
+9,350
New +$375K ﹤0.01% 825

Other funds holding MLYS

CP
Catalys Pacific Tokyo, Japan $229M AUM 100.3% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Virginia Retirement Systems's MLYS Position: Q2 2026 in Review

Virginia Retirement Systems increased its Mineralys Therapeutics (MLYS) stake by 27% in Q2 2026, buying an estimated $71.3K and bringing the position to 12,350 shares worth $333K. The position accounts for ﹤0.01% of the portfolio, ranked #1092.

Virginia Retirement Systems first reported a position in MLYS in Q4 2025 and has held it in 3 quarters since. The position peaked at $339K in Q4 2025. 226 funds tracked by Wall St. Rank hold MLYS as of Q2 2026.

  • Virginia Retirement Systems held 12,350 shares of Mineralys Therapeutics worth $333K as of Q2 2026.
  • Virginia Retirement Systems bought 2,600 Mineralys Therapeutics shares in Q2 2026, an estimated $71.3K.
  • Mineralys Therapeutics made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q2 2026, its #1092 holding.
  • Virginia Retirement Systems first reported a position in Mineralys Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Virginia Retirement Systems's Mineralys Therapeutics position peaked at $339K in Q4 2025.
  • 226 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q2 2026.

Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.